 CAMBRIDGE, Mass., Oct. 21, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. NASDAQ: GNCA, a biopharmaceutical company developing next-generation cancer immunotherapies, will host its third quarter 2021 corporate update conference call and live audio webcast on Thursday, October 28t h at 8:30 a.m. E.T. 